Cardiovasc drugs ther. impact factor
WebJACC: Heart Failure is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC).It publishes the most important findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal of the Journal is to improve our understanding of the disease, clinical trial, clinical … WebAlso covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. ... Year: Impact Factor (IF) Total Articles: Total Cites: 2024 (2024 update) 2.755-1938: 2024: 3.231: 86: 1772: 2024: 2.284: 58: 1272: ... Cardiovasc Ther Prev. Cardiovascular ...
Cardiovasc drugs ther. impact factor
Did you know?
WebClinical evaluation and laboratory analyses, including haemoglobin, renal function (creatinine, urea, cystatin-C); coagulation markers (INR, aPTT); inflammation markers (IL … WebCirc Cardiovasc Qual Outcomes. 2009;2(6):607–615. 27. Zeller T, Krankenberg H, Steinkamp H, et al. One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther. 2009;16(6):653–662. 28.
WebCardiovasc Drugs Ther. 2002 Sep;16(5):391-9. doi: 10.1023/a:1022130217463. ... Genetic factors, certain drugs and renal impairment may also contribute. Homocysteine has several potentially deleterious vascular actions. These include increased oxidant stress, impaired endothelial function, stimulation of mitogenesis, and induction of thrombosis ... WebCardiovascular Research is the international journal of the European Society of Cardiology for basic and translational research, spanning all topics within cardiology and cardiovascular biology. The journal aims to enhance insight into cardiovascular disease mechanisms and the prospects for innovation. The journal welcomes submission of papers ...
WebApr 4, 2024 · Cardiovascular Drugs and Therapy is a careful and accurate guide for clinicians and researchers to navigate new products and therapies in cardiovascular pharmacology that will remain an essential and timeless resource. ... Impact factor … Volumes and issues. Volume 37 February - April 2024. April 2024, issue 2; February … WebInitial statin dose after myocardial infarction and long-term cardiovascular outcomes. Aims Effective statin therapy is a cornerstone of secondary prevention after myocardial infarction (MI). Real-life statin dosing is nevertheless suboptimal and largely determined early after MI. We studied long-term outcome impact of initial statin dose after MI.
WebImpact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation Cardiovasc Drugs Ther. 2024 Oct;33(5):615-623. doi: 10.1007/s10557-019-06907-8. ... Risk Factors Stroke / diagnosis ...
WebThere are many factors influencing the treatment adherence of hypertensive patients. The aim of this study was to examine the effect of social support on the treatment adherence in hypertension in China. ... (r=0.568) had greater impact on treatment adherence than that from kinship (r=0.364) and nuclear family (r=0.262). ... Cardiovasc Drugs ... fzbfWebMay 27, 2024 · The impact score (IS) 2024 of Therapeutic Advances in Chronic Disease is 4.49, which is computed in 2024 as per its definition.Therapeutic Advances in Chronic Disease IS is increased by a factor of 0.05 and approximate percentage change is 1.13% when compared to preceding year 2024, which shows a rising trend. The impact score … fzbdeWebHoming in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic … attack on titan evolution perksWebCardiovasc is a medicine available in a number of countries worldwide. A list of US medications equivalent to Cardiovasc is available on the Drugs.com website. ... fzblg.cnWebScope. Journal of Cardiovascular Pharmacology is a peer reviewed, multidisciplinary journal that publishes original articles and pertinent review articles on basic and clinical aspects of cardiovascular pharmacology. The Journal encourages submission in all aspects of cardiovascular pharmacology/medicine including, but not limited to: stroke ... attack on titan evolution ksaverWeb13 rows · Journal Abbreviation: CARDIOVASC THER Journal ISSN: 1755-5914. ... Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on … fzbhiWebJournal impact factor : 0.91 ; Average acceptance to publication time (5-7 days) ... Therapeutics is additionally concerned with the identification and validation of biomarkers to either help drug improvement, or permit a stratified medicine approach in patients. ... J Cardiovasc Med Ther: 5(5): 1-1 . Radiofrequency control in cardio fibrillation. attack on titan evolution pvp